The scientific advisory committee

AVEO Oncology, an LG Chem company, and LG Chem Life Sciences joined together to form a Scientific Advisory Committee in Q1 2024. This esteemed group of experts in oncology research and clinical development were selected to advise and share their unique perspectives to further our mutual clinical strategy and business development goals. This group of top oncology experts will help guide drug development initiatives from discovery through commercialization. Notably, the Committee represents key areas of interest, including gastrointestinal, genitourinary, ovarian, lung, and head and neck cancers.

See our science

AVEO is dedicated to improving the lives of cancer patients by furthering drug discovery, development, and commercialization. But we can’t always do it alone.

See who we’re working with